• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Microbot Medical Inc. - Common Stock (NQ:MBOT)

    1.815 +0.045 (+2.54%)
    Streaming Delayed Price Updated: 2:34 PM EDT, Jun 11, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 439,845
    Open 1.780
    Bid (Size) 1.810 (800)
    Ask (Size) 1.820 (2,000)
    Prev. Close 1.770
    Today's Range 1.764 - 1.830
    52wk Range 1.600 - 4.670
    Shares Outstanding 67,158,044
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Microbot Medical® Announces a Notable Health System as the First in Michigan to Adopt the LIBERTY® Endovascular Robotic System
    First Midwest-based account reflects continued execution of the Company's Full Market Release strategy and expansion into additional U.S. territories 
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Secures the First Healthcare System in North Carolina to Adopt the LIBERTY® Endovascular Robotic System
    A leading academic center becomes the first user in the Southeast, Mid-Atlantic region 
    From Microbot Medical Inc.
    Via GlobeNewswire

    Performance

    YTD
    -14.0%
    -14.0%
    1 Month
    -17.1%
    -17.1%
    3 Month
    -36.3%
    -36.3%
    6 Month
    -24.4%
    -24.4%
    1 Year
    -30.2%
    -30.2%

    More News

    Read More
    News headline image
    Microbot Medical® Receives Its First International Regulatory Approval for the Commercialization of the LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Successfully Transitions to Commercial Operations as It Records Revenue Resulting from Its Limited Market Release During the First Quarter of 2026
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Announces the Addition of Senior Commercial Executive with Proven Track Record to Accelerate Commercial Readiness in Europe, the Middle East, and Asia (EMEA)
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Welcomes Updated Occupational Protection Guidelines from Leading Medical Societies, Strengthening Commercial Position of LIBERTY®
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® to Highlight Commercial Achievements Leading to the Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System at the 25th Annual Needham Virtual Healthcare Conference
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Commences Full Market Release (FMR) of the LIBERTY® Endovascular Robotic System in the U.S. at the Society of Interventional Radiology (SIR) Annual Scientific Meeting
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Emory Healthcare Successfully Completes Robotic Peripheral Endovascular Procedures using Microbot Medical®’s LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Strengthens LIBERTY® Endovascular Robotic System Position with Publication of its ACCESS PVI Pivotal Study in Leading Peer-Reviewed Medical Journal
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® to Participate at the 38th Annual Roth Conference
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company ↗
    Via Stocktwits
    News headline image
    Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
    From Microbot Medical Inc.
    Via GlobeNewswire
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Tampa General Hospital is the First Health System in Florida to Adopt the LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System
    From Microbot Medical Inc.
    Via GlobeNewswire
    News headline image
    Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S.
    From Microbot Medical Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Microbot Medical Inc. - Common Stock publicly traded?
    Yes, Microbot Medical Inc. - Common Stock is publicly traded.
    What exchange does Microbot Medical Inc. - Common Stock trade on?
    Microbot Medical Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Microbot Medical Inc. - Common Stock?
    The ticker symbol for Microbot Medical Inc. - Common Stock is MBOT on the Nasdaq Stock Market
    What is the current price of Microbot Medical Inc. - Common Stock?
    The current price of Microbot Medical Inc. - Common Stock is 1.815
    When was Microbot Medical Inc. - Common Stock last traded?
    The last trade of Microbot Medical Inc. - Common Stock was at 06/11/26 02:34 PM ET
    What is the market capitalization of Microbot Medical Inc. - Common Stock?
    The market capitalization of Microbot Medical Inc. - Common Stock is 121.89M
    How many shares of Microbot Medical Inc. - Common Stock are outstanding?
    Microbot Medical Inc. - Common Stock has 122M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.